These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1495526)

  • 21. [Angiotensin-converting enzyme inhibitors in heart failure].
    Gullestad L; Søyland E; Dolva LO; Kjekshus J
    Tidsskr Nor Laegeforen; 1987 Sep; 107(25):2112-6. PubMed ID: 2823410
    [No Abstract]   [Full Text] [Related]  

  • 22. [New momentum in cardiovascular therapy. Further development of ACE inhibitors: from captopril to lisinopril].
    Fortschr Med Suppl; 1988; 48():1-11. PubMed ID: 2904396
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparing angiotensin-converting enzyme inhibitor trial results in patients with acute myocardial infarction.
    Cody RJ
    Arch Intern Med; 1994 Sep; 154(18):2029-36. PubMed ID: 8092908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin converting enzyme inhibitor therapy.
    Róna G
    Ther Hung; 1991; 39(2):63-70. PubMed ID: 1948779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Captopril in the treatment of heart failure].
    Kékes E
    Acta Pharm Hung; 1997 Jul; 67(4):155-63. PubMed ID: 9289944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventing and reversing target organ damage by treatment of the renin-angiotensin system.
    Krakoff LR; Rajasekharaiah V
    Mt Sinai J Med; 1998 Mar; 65(2):125-32. PubMed ID: 9520516
    [No Abstract]   [Full Text] [Related]  

  • 27. [Ventricular "remodeling" after myocardial infarction].
    Cohen-Solal A; Himbert D; Guéret P; Gourgon R
    Arch Mal Coeur Vaiss; 1991 Jun; 84(6):847-53. PubMed ID: 1910327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of angiotensin-converting enzyme inhibitors in left ventricular dysfunction: results of the studies of left ventricular dysfunction in the context of other similar trials.
    Yusuf S; Garg R; McConachie D
    J Cardiovasc Pharmacol; 1993; 22 Suppl 9():S28-35. PubMed ID: 7514238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Trandolapril in the prevention of the sequelae of left ventricular systolic dysfunction after acute myocardial infarct].
    Buksa M
    Med Arh; 2000; 54(2):103-6. PubMed ID: 10934839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of angiotensin-converting enzyme inhibitors.
    Wyvratt MJ
    Clin Physiol Biochem; 1988; 6(3-4):217-29. PubMed ID: 2849521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
    Anavekar NS; McMurray JJ; Velazquez EJ; Solomon SD; Kober L; Rouleau JL; White HD; Nordlander R; Maggioni A; Dickstein K; Zelenkofske S; Leimberger JD; Califf RM; Pfeffer MA
    N Engl J Med; 2004 Sep; 351(13):1285-95. PubMed ID: 15385655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of chronic heart failure with angiotensin-converting enzyme inhibitors].
    Schofer J
    Dtsch Med Wochenschr; 1988 Oct; 113(43):1684-9. PubMed ID: 2846252
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II).
    Swedberg K; Held P; Kjekshus J; Rasmussen K; Rydén L; Wedel H
    N Engl J Med; 1992 Sep; 327(10):678-84. PubMed ID: 1495520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of severe heart failure complicating chronic hemodialysis in which angiotensin converting enzyme inhibitor was markedly effective].
    Nomura S; Takagi N; Oda H; Ikeda Y; Yoshimura H; Kimura K; Minamisawa K; Shionoiri H; Kaneko Y; Onishi T
    Nihon Jinzo Gakkai Shi; 1987 Oct; 29(10):1281-6. PubMed ID: 2831419
    [No Abstract]   [Full Text] [Related]  

  • 35. Converting enzyme inhibitors (captopril, enalapril, perindopril) prevent early-post infarction ventricular fibrillation in the anaesthetized rat.
    Ribuot C; Rochette L
    Cardiovasc Drugs Ther; 1987; 1(1):51-5. PubMed ID: 2856461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of events with angiotensin-converting enzyme inhibition (the PEACE study design). Prevention of Events with Angiotensin-Converting Enzyme Inhibition.
    Pfeffer MA; Domanski M; Rosenberg Y; Verter J; Geller N; Albert P; Hsia J; Braunwald E
    Am J Cardiol; 1998 Aug; 82(3A):25H-30H. PubMed ID: 9719019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of converting enzyme inhibitors in myocardial infarction].
    Soyeur D
    Rev Med Liege; 1995 May; 50(5):201-3. PubMed ID: 7784746
    [No Abstract]   [Full Text] [Related]  

  • 38. Angiotensin-converting-enzyme inhibitors in treatment of heart failure.
    Lancet; 1985 Oct; 2(8459):811-2. PubMed ID: 2864536
    [No Abstract]   [Full Text] [Related]  

  • 39. Additional follow-up from the ABCD trial in patients with type 2 diabetes and hypertension.
    Schrier RW; Estacio RO
    N Engl J Med; 2000 Dec; 343(26):1969. PubMed ID: 11186674
    [No Abstract]   [Full Text] [Related]  

  • 40. Angiotensin-converting inhibitors in patients with congestive heart failure: a class effect?
    Pitt B
    Am J Cardiol; 1991 Jul; 68(1):106-8. PubMed ID: 2058542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.